LoginSignup
ECI

EIS

Stock
Stock
ISIN: TRAECILC91E0
Ticker: ECILC.E
TRAECILC91E0
ECILC.E

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

EIS has so far distributed $0.0386 in 2026. The next dividend will be paid on 08.05.2027

$0.0438

CHART BY

Frequently asked questions

The market capitalization of EIS is $1.03B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
EIS's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.0503. EPS indicates the company's profitability on a per-share basis.
Currently, 1 analysts cover EIS's stock, with a consensus target price of $0.0674. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, EIS reported a revenue of $210.30M.
EIS's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $14.87M. EBITDA measures the company's overall financial performance.
EIS has a free cash flow of $28.40M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
EIS employs approximately 1,071 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
The free float of EIS is 128.61M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$1.03B
EPS (TTM) 
-$0.0503
Free Float 
128.61M
Revenue (TTM) 
$210.30M
EBITDA (TTM) 
$14.87M
Free Cashflow (TTM) 
$28.40M

Pricing

52W span
$1.293$3.054

Analyst Ratings

The price target is $0.0674 and the stock is covered by 1 analysts.

Buy

0

Hold

1

Sell

0

Information

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS is a holding company, which engages in the investment and management business. It operates through the Health and Real Estate Development segments. The Health segment is the production and sale of human health and veterinary medicine. The Real Estate Development segment is the sale and lease of properties and lands. The company was founded by Mehmet Nejat Eczacibasi, Melih Eczacibasi, Haluk Eczacibasi, Kemal Eczacibasi, and M. Sakir Eczacibas on October 24, 1951 and is headquartered in Istanbul, Turkey.

Employees
1,071
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
TRAECILC91E0
Primary Ticker
ECILC.E
Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin